Corrigendum: Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
Main Authors: | Yunxiong Wei, Yaqing Cao, Rui Sun, Lin Cheng, Xia Xiong, Xin Jin, Xiaoyuan He, Wenyi Lu, Mingfeng Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.632775/full |
Similar Items
-
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
by: Yunxiong Wei, et al.
Published: (2020-11-01) -
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia
by: Jing-dong Zhou, et al.
Published: (2019-06-01) -
Evaluating venetoclax and its potential in treatment-naïve acute myeloid leukemia
by: Knight T, et al.
Published: (2019-04-01) -
Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia
by: Huber H, et al.
Published: (2017-02-01) -
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models
by: Alice C. O’Farrell, et al.
Published: (2020-10-01)